Variant report
Variant | esv3345886 |
---|---|
Chromosome Location | chr7:119204050-119225361 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:75)
- CpG islands (count:0)
- Chromatin interactive region (count:9)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr7:119212161-119212254 | A549 | lung: | n/a | n/a |
2 | CTCF | chr7:119212250-119212368 | GM12892 | blood: | n/a | n/a |
3 | CTCF | chr7:119211960-119212110 | HMEC | breast: | n/a | n/a |
4 | CTCF | chr7:119212249-119212315 | HUVEC | blood vessel: | n/a | n/a |
5 | CTCF | chr7:119212144-119212432 | K562 | blood: | n/a | n/a |
6 | CTCF | chr7:119212239-119212387 | H1-hESC | embryonic stem cell: | n/a | n/a |
7 | CTCF | chr7:119212260-119212410 | HCT-116 | colon: | n/a | n/a |
8 | CTCF | chr7:119212280-119212430 | GM12871 | blood: | n/a | n/a |
9 | CTCF | chr7:119210498-119210570 | GM20000 | blood: | n/a | n/a |
10 | CTCF | chr7:119212238-119212332 | GM12878 | blood: | n/a | n/a |
11 | CTCF | chr7:119212120-119212270 | BE2_C | brain: | n/a | n/a |
12 | CTCF | chr7:119212298-119212367 | MCF-7 | breast: | n/a | n/a |
13 | CTCF | chr7:119213180-119213330 | WERI-Rb-1 | eye: | n/a | n/a |
14 | CTCF | chr7:119212320-119212470 | RPTEC | kidney: | n/a | n/a |
15 | CTCF | chr7:119212200-119212350 | HCM | heart: | n/a | n/a |
16 | CTCF | chr7:119212283-119212336 | GM19238 | blood: | n/a | n/a |
17 | CTCF | chr7:119213213-119213250 | HepG2 | liver: | n/a | n/a |
18 | CTCF | chr7:119212256-119212355 | GM19239 | blood: | n/a | n/a |
19 | CTCF | chr7:119212154-119212444 | GM12878 | blood: | n/a | n/a |
20 | CTCF | chr7:119212226-119212348 | HepG2 | liver: | n/a | n/a |
21 | CTCF | chr7:119212240-119212390 | HVMF | connective: | n/a | n/a |
22 | CTCF | chr7:119212269-119212339 | A549 | lung: | n/a | n/a |
23 | CTCF | chr7:119212194-119212349 | Medullo | brain: | n/a | n/a |
24 | CTCF | chr7:119212180-119212330 | K562 | blood: | n/a | n/a |
25 | CTCF | chr7:119212240-119212390 | HepG2 | liver: | n/a | n/a |
26 | CTCF | chr7:119212280-119212430 | RPTEC | kidney: | n/a | n/a |
27 | CTCF | chr7:119212255-119212361 | GM19240 | blood: | n/a | n/a |
28 | CTCF | chr7:119212274-119212301 | Hela-S3 | cervix: | n/a | n/a |
29 | CTCF | chr7:119212180-119212330 | HMEC | breast: | n/a | n/a |
30 | CTCF | chr7:119212180-119212330 | WERI-Rb-1 | eye: | n/a | n/a |
31 | CTCF | chr7:119212100-119212250 | HVMF | connective: | n/a | n/a |
32 | CTCF | chr7:119212140-119212290 | NB4 | blood: | n/a | n/a |
33 | CTCF | chr7:119212270-119212286 | K562 | blood: | n/a | n/a |
34 | CTCF | chr7:119212219-119212248 | LNCaP | prostate: | n/a | n/a |
35 | CTCF | chr7:119212175-119212430 | Gliobla | brain: | n/a | n/a |
36 | CTCF | chr7:119212187-119212388 | SK-N-SH_RA | brain: | n/a | n/a |
37 | E2F4 | chr7:119223659-119223822 | MCF10A-Er-Src | breast: | n/a | n/a |
38 | GATA3 | chr7:119217783-119217960 | SH-SY5Y | brain: | n/a | n/a |
39 | GATA3 | chr7:119222967-119223124 | SH-SY5Y | brain: | n/a | chr7:119222971-119222981 |
40 | MAFK | chr7:119224729-119224759 | K562 | blood: | n/a | n/a |
41 | MAFK | chr7:119210725-119210747 | HepG2 | liver: | n/a | n/a |
42 | MAFK | chr7:119222985-119223141 | HepG2 | liver: | n/a | n/a |
43 | POLR2A | chr7:119219009-119219183 | K562 | blood: | n/a | n/a |
44 | POLR2A | chr7:119224192-119225293 | K562 | blood: | n/a | n/a |
45 | POLR2A | chr7:119212219-119212415 | K562 | blood: | n/a | n/a |
46 | POLR2A | chr7:119204415-119204526 | GM12878 | blood: | n/a | n/a |
47 | POLR2A | chr7:119205723-119205832 | MCF10A-Er-Src | breast: | n/a | n/a |
48 | POLR2A | chr7:119221662-119221862 | K562 | blood: | n/a | n/a |
49 | POLR2A | chr7:119207025-119207563 | K562 | blood: | n/a | n/a |
50 | POLR2A | chr7:119213681-119213759 | MCF-7 | breast: | n/a | n/a |
No data |
(count:9 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:119211056..119214261-chr7:119214480..119218185,4 | K562 | blood: | |
2 | chr7:119215904..119218529-chr7:119221309..119224669,3 | K562 | blood: | |
3 | chr7:119212184..119214604-chr7:119220970..119224685,3 | K562 | blood: | |
4 | chr7:119212184..119216632-chr7:119220970..119225768,5 | K562 | blood: | |
5 | chr7:119215904..119218529-chr7:119221309..119224669,3 | K562 | blood: | |
6 | chr7:119212184..119216632-chr7:119220970..119225768,5 | K562 | blood: | |
7 | chr7:119202572..119205180-chr8:103798970..103800546,2 | MCF-7 | breast: | |
8 | chr7:119211056..119214261-chr7:119214480..119218185,4 | K562 | blood: | |
9 | chr7:119212184..119214604-chr7:119220970..119224685,3 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000256882 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs529053407 | chr7:119204449-119204450 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs4129182 | chr7:119204483-119204484 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs533980585 | chr7:119204503-119204504 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs386717215 | chr7:119205741-119205742 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs73719952 | chr7:119205742-119205743 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs112051040 | chr7:119205811-119205812 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs182862742 | chr7:119205823-119205824 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs535739053 | chr7:119205831-119205832 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs563636889 | chr7:119206607-119206608 | Flanking Bivalent TSS/Enh Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs76785193 | chr7:119206618-119206619 | Flanking Bivalent TSS/Enh Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs144644641 | chr7:119206652-119206653 | Flanking Bivalent TSS/Enh Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs189196934 | chr7:119206702-119206703 | Flanking Bivalent TSS/Enh Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs79338637 | chr7:119206710-119206711 | Flanking Bivalent TSS/Enh Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs112491556 | chr7:119206753-119206754 | Flanking Bivalent TSS/Enh Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs528606894 | chr7:119206768-119206769 | Flanking Bivalent TSS/Enh Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs554263881 | chr7:119206808-119206809 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
17 | rs148641883 | chr7:119206822-119206823 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
18 | rs202064029 | chr7:119206841-119206842 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
19 | rs74592364 | chr7:119206848-119206849 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
20 | rs115245597 | chr7:119206862-119206863 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
21 | rs571690271 | chr7:119206874-119206875 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
22 | rs200795069 | chr7:119206926-119206927 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
23 | rs146830801 | chr7:119206929-119206930 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
24 | rs201324249 | chr7:119206932-119206933 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
25 | rs141761800 | chr7:119206939-119206940 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
26 | rs535261570 | chr7:119206961-119206962 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
27 | rs530956422 | chr7:119207005-119207006 | Flanking Bivalent TSS/Enh Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs57693866 | chr7:119207033-119207034 | Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs558169578 | chr7:119207045-119207046 | Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs556904616 | chr7:119207046-119207047 | Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs191251385 | chr7:119207054-119207055 | Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs376748421 | chr7:119207055-119207056 | Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs183799737 | chr7:119207072-119207073 | Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs541316757 | chr7:119207108-119207109 | Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs188371326 | chr7:119207125-119207126 | Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs565393084 | chr7:119207126-119207127 | Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs181240490 | chr7:119207202-119207203 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs150825648 | chr7:119207210-119207211 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs78714661 | chr7:119207215-119207216 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs543447636 | chr7:119207218-119207219 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs112093572 | chr7:119207286-119207287 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs116019414 | chr7:119207303-119207304 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs577699359 | chr7:119207332-119207333 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs555600938 | chr7:119207347-119207348 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs543473380 | chr7:119207363-119207364 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs76642276 | chr7:119207392-119207393 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs545496814 | chr7:119207395-119207396 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs565412085 | chr7:119207480-119207481 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs116316470 | chr7:119207504-119207505 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs112776304 | chr7:119207508-119207509 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 23792589 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Non-small cell lung cancer | 19889201 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Autism | 18414403 | CNVD |
Autism | 19401682 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Melanoma | 19188590 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:119206600-119206800 | Bivalent/Poised TSS | Breast Myoepithelial Primary Cells | Breast |
2 | chr7:119206600-119207200 | Flanking Bivalent TSS/Enh | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr7:119206800-119207000 | Flanking Bivalent TSS/Enh | Breast Myoepithelial Primary Cells | Breast |
4 | chr7:119207000-119207200 | Bivalent/Poised TSS | Breast Myoepithelial Primary Cells | Breast |
5 | chr7:119212000-119213000 | Enhancers | Brain Substantia Nigra | brain |
6 | chr7:119212200-119212800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
7 | chr7:119212600-119213000 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr7:119213000-119218200 | Weak transcription | Brain Substantia Nigra | brain |
9 | chr7:119217400-119219000 | Enhancers | Brain Hippocampus Middle | brain |
10 | chr7:119218200-119219000 | Enhancers | Brain Substantia Nigra | brain |